Stay updated on Pembrolizumab Post-ASCT in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    This change updates the page’s system/release revision label from v3.5.2 to v3.5.3, without altering the study record content.
    Difference
    0.1%
    Check dated 2026-04-26T15:16:14.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No substantive changes to content or features.
    Difference
    0.1%
    Check dated 2026-04-19T12:47:06.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0; previous revision v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-21T08:37:55.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page shows a revision from v3.4.2 to v3.4.3. This appears to be a minor update with no changes to study content.
    Difference
    0.1%
    Check dated 2026-03-06T18:42:56.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Site-level revision notes show Revision: v3.4.2 with dates 2026-01-26 and 2026-02-12, replacing v3.4.1; this does not affect the study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-13T12:38:31.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. No visible changes to study content or navigation.
    Difference
    0.1%
    Check dated 2026-02-05T17:19:47.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Post-ASCT in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page.